About the Authors
- Mohammad Atefi
-
Contributed equally to this work with: Mohammad Atefi, Erika von Euw
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Erika von Euw
-
Contributed equally to this work with: Mohammad Atefi, Erika von Euw
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Narsis Attar
-
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Charles Ng
-
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Connie Chu
-
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Deliang Guo
-
Affiliation Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America
- Ramin Nazarian
-
Affiliation Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, California, United States of America
- Bartosz Chmielowski
-
Affiliation Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- John A. Glaspy
-
Affiliations Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America, Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Begonya Comin-Anduix
-
Affiliations Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center at University of California Los Angeles, Los Angeles, California, United States of America
- Paul S. Mischel
-
Affiliations Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Roger S. Lo
-
Affiliations Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, California, United States of America, Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, United States of America
- Antoni Ribas
-
* E-mail: aribas@mednet.ucla.edu
Affiliations Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America, Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center at University of California Los Angeles, Los Angeles, California, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts. Antoni Ribas has has served as a consultant and has received honoraria from Hoffman-La Roche and Plexxikon, the makers of vemurafenib. This does not alter the authors' adherence to all the PLoS ONE policies of the manuscript.
Author Contributions
Conceived and designed the experiments: MA EvE BC JAG BC-A PSM RSL AR. Performed the experiments: MA EvE NA CN CC DG RN BC-A. Analyzed the data: RN BC JAG BC-A PSM RSL AR. Contributed reagents/materials/analysis tools: MA EvE NA CN DG BC JAG BC-A PSM RSL AR. Wrote the manuscript: MA EvE RSL AR.